Abstract:Adenosine triphosphate (ATP) acts on P2X receptors to initiate signal transmission. P2X(7) receptors play a role in the pathophysiological process of myocardial ischemic injury. Long noncoding RNAs (lncRNAs) participate in numerous biological functions independent of protein translation. LncRNAs are implicated in nervous system diseases. This study investigated the effects of NONRATT021972 small interference RNA (siRNA) on the pathophysiologic processes mediated by P2X(7) receptors in stellate ganglia (SG) after myocardial ischemic injury. Our results demonstrated that the expression of NONRATT021972 in SG was significantly higher in the myocardial ischemic (MI) group than in the control group. Treatment of MI rats with NONRATT021972 siRNA, the P2X(7) antagonist brilliant blue G (BBG), or P2X(7) siRNA improved the histology of injured ischemic cardiac tissues and decreased the elevated concentrations of serum myocardial enzymes, creatine kinase (CK), CK isoform MB (CK-MB), lactate dehydrogenase (LDH) and aspartate aminotransferase (AST) compared to the MI rats. NONRATT021972 siRNA, BBG, or P2X(7) siRNA treatment in MI rats decreased the expression levels of P2X(7) immunoreactivity, P2X(7) messenger RNA (mRNA), and P2X(7) protein, interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and phosphorylated p38 mitogen-activated protein kinase (p38 MAPK) in the SG compared to MI rats. NONRATT021972 siRNA treatment prevented the pathophysiologic processes mediated by P2X(7) receptors in the SG after myocardial ischemic injury.

Correction To: LncRNA NONRATT021972 Involved the Pathophysiologic Processes Mediated by P2X7 Receptors in Stellate Ganglia after Myocardial Ischemic Injury

Correction To: Long Noncoding NONRATT021972 Sirna Normalized Abnormal Sympathetic Activity Mediated by the Upregulation of P2X7 Receptor in Superior Cervical Ganglia after Myocardial Ischemia

Corrigendum to “from Phenotype to Gene: Detecting Disease‐specific Gene Functional Modules Via a Text‐based Human Disease Phenotype Network Construction” [FEBS Lett. 584 (2010) 3635–3643]

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

LncRNA PFL Contributes to Cardiac Fibrosis by Acting As a Competing Endogenous RNA of Let-7D: Erratum

[Corrigendum] Exosomal microRNA‑4516, microRNA‑203 and SFRP1 are potential biomarkers of acute myocardial infarction

Correction To: MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Correction To: TAOK1 Negatively Regulates IL-17-mediated Signaling and Inflammation

RETRACTED: Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes Dis DOI: 10.1016/J.gendis.2020.07.005]

Correction to: LncRNA H19 initiates microglial pyroptosis and neuronal death in retinal ischemia/reperfusion injury

LncRNA NONRATT021972 Involved the Pathophysiologic Processes Mediated by P2X7 Receptors in Stellate Ganglia after Myocardial Ischemic Injury

Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer (Nature Nanotechnology, (2019), 14, 4, (388-397), 10.1038/s41565-019-0381-6)

Corrigendum for “lncrna EPB41L4A-AS1 Regulates Glycolysis and Glutaminolysis by Mediating Nucleolar Translocation of HDAC2” [ebiomedicine 41 (2019) 200–213]

Corrigendum: Single-cell RNA Sequencing of Peripheral Blood Mononuclear Cells from Acute Myocardial Infarction.

Corrigendum: Transcriptional progressive patterns from mild to severe renal ischemia/reperfusion-induced kidney injury in mice

Correction: LncRNA-MM2P Identified as a Modulator of Macrophage M2 Polarization

Correction To: Proteogenomic Characterization and Comprehensive Integrative Genomic Analysis of Human Colorectal Cancer Liver Metastasis

Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer

Corrigendum to “FUNDC1 Insufficiency Sensitizes High Fat Diet Intake-Induced Cardiac Remodeling and Contractile Anomaly Through ACSL4-mediated Ferroptosis” [metabolism 122 (september 2021) 154840]

Correction: Fan et al. Progress in the Preclinical and Clinical Study of Resveratrol for Vascular Metabolic Disease. Molecules 2022, 27, 7524